Memory Plus, a memory enhancing drug developed by the Central Drug Research Institute (CDRI), appears to be well entrenched in public memory. The drug has notched up impressive sales during its first three months of launch.
According to CDRI scientists some Rs 10 lakh worth packets were sold in the metros where it was initially launched. Backed by an intensive campaign, Memory Plus claims to have attracted consumer attention for its unusual properties of enhancing the memory.
The scientists said the drug was launched just before the examination season which made students go for it in a major way. Manufactured by Velvette International Pharma Products which has bought the CDRI know-how, the drug is hailed as a miracle of the Indian ayurveda system of medicine.
Flush with the success of the drug in the Indian market, the company is planning to launch Memory Plus in Europe and the CIS.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app